Clinical trial
A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor
NCT00187031 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2002
- Completion date
- October 31, 2007
- Enrollment
- 37 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.